[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kumar et al., 2020 - Google Patents

Nanoparticle-based drugs and formulations: current status and emerging applications

Kumar et al., 2020

View PDF
Document ID
14862054088633665057
Author
Kumar R
Dalvi S
Siril P
Publication year
Publication venue
ACS Applied Nano Materials

External Links

Snippet

In the foreseeable future, the pharmaceuticals market, nanomedicine, and healthcare systems will largely depend on the drug nanoparticle formulation technology. Perceiving this, scientists around the world are reporting each day a significant amount of research …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds

Similar Documents

Publication Publication Date Title
Kumar et al. Nanoparticle-based drugs and formulations: current status and emerging applications
Da Silva et al. Nanonization techniques to overcome poor water-solubility with drugs
Malamatari et al. Pharmaceutical nanocrystals: production by wet milling and applications
Joshi et al. Nanocrystalization: an emerging technology to enhance the bioavailability of poorly soluble drugs
Shrimal et al. A review on novel methodologies for drug nanoparticle preparation: Microfluidic approach
Kumari et al. Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs
Khadka et al. Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability
Ravichandran Nanoparticles in drug delivery: potential green nanobiomedicine applications
Franco et al. Nanoparticles and nanocrystals by supercritical CO2-assisted techniques for pharmaceutical applications: a review
Müller et al. State of the art of nanocrystals–special features, production, nanotoxicology aspects and intracellular delivery
Chen et al. Nanonization strategies for poorly water-soluble drugs
Leleux et al. Recent advancements in mechanical reduction methods: Particulate systems
Leone et al. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations
Elizondo et al. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids
Fernandes et al. A review on solubility enhancement of carvedilol—a BCS class II drug
Kumar et al. Acoustic cavitation-assisted formulation of solid lipid nanoparticles using different stabilizers
Dubey Impact of nanosuspension technology on drug discovery and development
Dang et al. Effect of ultrasonication on self-assembled nanostructures formed by amphiphilic positive-charged copolymers and negative-charged drug
Wu et al. Controlling nucleation and fabricating nanoparticulate formulation of sorafenib using a high-gravity rotating packed bed
Bhowmik et al. Nanosuspension-A novel approaches in drug delivery system
Kumar Solubility and bioavailability of fenofibrate nanoformulations
Chavhan et al. Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects
Sunder et al. Methods of nanonization of drugs for enhancing their dissolution
Pravin et al. Different techniques for preparation of nanosuspension with reference to its characterisation and various applications-a review
Hirlekar et al. Solid lipid nanoparticles and nanostructured lipid carriers: a review